Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Phase 1 trial of a novel combination of KRAS-targeted TCR-engineered T-cells with therapeutic vaccine in metastatic solid cancers; registry record with no results posted; early-stage feasibility and safety assessment.
This is a Phase 2 interventional trial registration with no results yet posted; it describes planned enrollment and study design only, making it an early-stage assessment of a novel cell therapy approach.
This is a Phase 2 interventional trial registration with no results reported; the study is actively recruiting and has not yet yielded efficacy or safety data.